HomeOpen Access NewsResearch & Innovation

Research & Innovation

Seeking comparative advantage: The EU’s push for a new R&I programme

Jan Palmowski, Secretary-General of The Guild of European Research-Intensive Universities in Brussels, emphasises the need to seek comparative advantages in the European Union’s pursuit of a new R&I programme amid Donald Trump’s push for AI.

A vision on remote decentralised clinical trials

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.

SEA-TITAN: Wave energy technology convergence

Aleix Maria Arenas from Wedge Global tells us what we need to know about the H2020-funded SEA-TITAN project that encourages a step-change towards wave energy technology convergence.

Enduring research: The constant threat of influenza virus outbreaks

Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.

Plant essential oils: Nature’s insecticides

Joel R. Coats, Distinguished Professor, Department of Entomology, Iowa State University provides an introduction and analysis of plant essential oils – nature’s insecticides.

High voltage agriculture creates sustainable food supply

Professor Koichi Takaki discusses how combining electricity and biology could create a sustainable food supply.

Tree crop productivity: The microbial terroir of vineyards

Philippe Rolshausen from University of California, Riverside shares with us his research and extension program that focuses on understanding specific biotic and abiotic factors that limit tree crop productivity.

Economic geography research: Manufacturing recovery in industrial regions?

Peter Sunley from the University of Southampton investigates the potential of advanced manufacturing for spatial rebalancing in this fascinating economic geography research focus.

Bioquell’s rapid bio-decontamination service (RBDS) is effective against COVID-19

Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.

Vitamin A joins endocrine disruption

Here, Alberto Mantovani discusses how Vitamin A joins endocrine disruption, an increasingly crucial issue.

Oligomers: The advanced material for the design of nanomachines

Professor Vladik Avetisov and his teams are searching for oligomeric compositions, which are only a few nanometres in size, that behaves like nonlinear mechanical systems, more of which are detailed here in this chemical physics analysis.

Pyroptotic cell death: Controlled self-destruct that causes inflammation and disease

Associate Professor Petr Broz discusses pyroptotic cell death, the controlled cellular explosion that can harm your health.

10% of COVID-19 patients with diabetes die within 7 days of hospitalisation

New research has found that one in ten COVID-19 patients with diabetes dies within seven days of hospital admission.

Finland: A framework for genetic research

Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.

How battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells

Dr Carlos Ziebert, head of IAM-AWP’s Calorimeter Center, KIT, explains how battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells.

A gateway to transport and energy research: The Innovation and Networks Executive Agency

Dirk Beckers, Director of the Innovation and Networks Executive Agency, charts the important work of the organisation in supporting transport and energy research plus the ambitious Horizon Europe research and innovation framework programme (2021-2027).

Could placenta cells save patients with severe COVID-19?

Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders